{
    "SPADE_UN_26792": {
        "Sequence Information": {
            "Peptide Name": "C18-LVTX-9",
            "Sequence": "ASIGALIQKAIALIKAKAA",
            "Sequence Length": 19,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Fatty Acid Modification of the Anticancer Peptide LVTX-9 to Enhance Its Cytotoxicity against Malignant Melanoma Cells",
                    "Pubmed ID": "34941705",
                    "Reference": "Toxins (Basel). 2021;13:867",
                    "Author": "Li F, Wu S, Chen N, Zhu J, Zhao X, Zhang P, Zeng Y, Liu Z",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34941705"
                }
            ],
            "Mass": 1851.28,
            "PI": 10.3,
            "Net Charge": 3,
            "Hydrophobicity": 1.15,
            "Frequent Amino Acids": "AIK",
            "Absent Amino Acids": "CDEFHMNOPRTUVWY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 13,
            "Polar Residues": 6,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26792",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_26792",
                    "Similarity": 1.0,
                    "Sequence": "ASIGALIQKAIALIKAKAA"
                },
                {
                    "SPADE_ID": "SPADE_N_13246",
                    "Similarity": 0.8,
                    "Sequence": "KAKAKKAKWAK"
                },
                {
                    "SPADE_ID": "SPADE_UN_21004",
                    "Similarity": 0.8,
                    "Sequence": "KAKAKKAKWAK"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:10% Hemolysis=25 µM,Human erythrocytes:50% Hemolysis=50 µM",
            "Target Organism": "Mouse skin melanoma B16-F10(IC50=4.4±0.2µM),Mouse skin melanoma B16-F10(IC50=8.5±2.9µM),Mouse fibrosarcoma L929(IC50=3.6±1.0µM),Human lung carcinoma A549(IC50=6.2±1.4µM),Mouse breast cancer 4T1(IC50=7.6±1.3µM),Human hepatocellular carcinoma HepG2(IC50=7.0±1.0µM),Human cervical carcinoma HeLa(IC50=4.7±1.4µM)"
        }
    }
}